Scopus BioPharma Inc. (SCPS)

0.00

-0.00 (-100.00%)

At close: Feb 28, 2025, 3:00 PM

Scopus BioPharma Cash Flow Statement

Table Mode

Year	FY22	FY21	FY20	FY19	FY18
Net Income	-11.71M	-26.95M	-10.86M	-2.69M	-685.96K
Depreciation & Amortization	1.73K	1.5K	1.44K	664.00	n/a
Stock-Based Compensation	351.72K	669.6K	290.41K	213.65K	69.64K
Other Working Capital	-3B	-2.94B	-35.24K	n/a	n/a
Other Non-Cash Items	n/a	13.47M	6.92M	89.15K	n/a
Deferred Income Tax	n/a	-1.46M	n/a	n/a	n/a
Change in Working Capital	3.23M	2.84M	1.15M	355.23K	-131K
Operating Cash Flow	-8.13M	-11.42M	-2.53M	-2.12M	-747.32K
Capital Expenditures	-1.55K	-2K	n/a	-4.25K	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.55K	-2K	n/a	-4.25K	n/a
Debt Repayment	n/a	-104.5K	2.19M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	241.94K	-2.44M	-1.11M	407.21K	59.15K
Financial Cash Flow	241.94K	17.56M	4.35M	2.18M	597.63K
Net Cash Flow	-7.82M	6.11M	1.8M	35.09K	-156.56K
Free Cash Flow	-8.13M	-11.43M	-2.53M	-2.12M	-747.32K